Cyclosporin-A (CsA) is an immunosuppressant associated with acute kidney injury and chronic kidney disease. Nephrotoxicity associated with CsA involves the increase in afferent and efferent arteriole resistance, decreased renal blood flow (RBF) and glomerular filtration. The aim of this study was to evaluate the effect of Endothelin-1 (ET-1) receptor blockade with bosentan (BOS) and macitentan (MAC) antagonists on altered renal function induced by CsA in normotensive and hypertensive animals. Wistar and genetically hypertensive rats (SHR) were separated into control group, CsA group that received intraperitoneal injections of CsA (40 mg/kg) for 15 days, CsA+BOS and CsA+MAC that received CsA and BOS (5 mg/kg) or MAC (25 mg/kg) by gavage for ...
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. The mechanism of ...
AIM: Cyclosporine-A (CyA) is used to control transplant rejections and to treat autoimmune diseases...
Aim: Cyclosporine-A (CyA) is used to control transplant rejections and to treat autoimmune diseases....
Cyclosporin-A (CsA) is an immunosuppressant associated with acute kidney injury and chronic kidney d...
Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Endothelin (Et)...
Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstr...
Cyclosporine A (CsA), a widely used immunosuppressive agent, causes renal vasoconstriction and syste...
Role of endothelin in cyclosporine-induced glomerular dysfunction. Since recent studies indicate tha...
Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine ABackgroundEndothe...
Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. Cyclosporin A ...
Site selective regulation in the kidney of endothelin and its receptor subtypes by cyclosporine. End...
Role of endothelin in cyclosporine-induced glomerular dysfunction. Since recent studies indicate tha...
Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. Cyclosporin A ...
Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine ABackgroundEndothe...
Site selective regulation in the kidney of endothelin and its receptor subtypes by cyclosporine. End...
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. The mechanism of ...
AIM: Cyclosporine-A (CyA) is used to control transplant rejections and to treat autoimmune diseases...
Aim: Cyclosporine-A (CyA) is used to control transplant rejections and to treat autoimmune diseases....
Cyclosporin-A (CsA) is an immunosuppressant associated with acute kidney injury and chronic kidney d...
Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Endothelin (Et)...
Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstr...
Cyclosporine A (CsA), a widely used immunosuppressive agent, causes renal vasoconstriction and syste...
Role of endothelin in cyclosporine-induced glomerular dysfunction. Since recent studies indicate tha...
Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine ABackgroundEndothe...
Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. Cyclosporin A ...
Site selective regulation in the kidney of endothelin and its receptor subtypes by cyclosporine. End...
Role of endothelin in cyclosporine-induced glomerular dysfunction. Since recent studies indicate tha...
Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. Cyclosporin A ...
Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine ABackgroundEndothe...
Site selective regulation in the kidney of endothelin and its receptor subtypes by cyclosporine. End...
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. The mechanism of ...
AIM: Cyclosporine-A (CyA) is used to control transplant rejections and to treat autoimmune diseases...
Aim: Cyclosporine-A (CyA) is used to control transplant rejections and to treat autoimmune diseases....